Lexapro is FDA-approved for both anxiety and depression. Specifically, it’s indicated for major depressive disorder (MDD) in adults and adolescents 12 and older, and for generalized anxiety disorder (GAD) in adults and children 7 and older. It’s one of a relatively small number of medications that carries formal approval for both conditions, which is one reason it’s so widely prescribed.
How Lexapro Works for Both Conditions
Lexapro belongs to a class of drugs called selective serotonin reuptake inhibitors, or SSRIs. It works by blocking the brain’s reabsorption of serotonin, a chemical messenger involved in mood regulation. With more serotonin available between nerve cells, signaling improves in the circuits that govern both mood and anxiety responses.
What makes Lexapro unusual among SSRIs is its precision. It’s the most selective drug in its class, meaning it concentrates almost entirely on the serotonin system without meaningfully affecting other brain chemicals like dopamine or norepinephrine. It also has very low affinity for the receptors that commonly produce side effects with other medications, including histamine receptors (linked to drowsiness and weight gain) and muscarinic receptors (linked to dry mouth and constipation). This selectivity is part of why Lexapro is generally considered one of the better-tolerated antidepressants.
What It’s Officially Approved For
The FDA has approved Lexapro for two specific diagnoses:
- Major depressive disorder (MDD) in adults and adolescents 12 years and older
- Generalized anxiety disorder (GAD) in adults and children 7 years and older
GAD is characterized by persistent, hard-to-control worry about everyday things like health, finances, work, or family, lasting six months or more. It’s distinct from situational stress or occasional nervousness. Lexapro’s approval for GAD was based on three separate 8-week clinical trials, all of which showed significantly greater improvement compared to placebo on standard anxiety rating scales.
Beyond these official approvals, doctors also prescribe Lexapro off-label for other anxiety-related conditions, including social anxiety disorder and panic disorder. Off-label doesn’t mean unproven or risky. It simply means the manufacturer hasn’t sought formal FDA approval for that specific use, often because the existing approval already covers much of the patient population.
How Long It Takes to Work
One of the most common frustrations with Lexapro is the waiting period. You may notice early improvements in sleep, energy, and appetite within the first one to two weeks. But the full therapeutic effect on mood and anxiety typically takes four to six weeks to develop.
This delay matters because it means side effects often show up before benefits do. If you’re in the first couple of weeks and feeling no better (or even slightly worse), that’s a normal part of the adjustment period, not a sign the medication isn’t working. Most prescribers recommend giving it at least a full month before judging whether it’s effective.
Typical Dosing
The recommended starting dose is the same for both depression and anxiety: 10 mg once daily for adults. If needed, the dose can be increased to a maximum of 20 mg daily after at least one week. For adolescents and children, the starting dose is also 10 mg, but dose increases happen more slowly, with a minimum of two to three weeks between adjustments depending on age and condition.
The fact that dosing is identical for anxiety and depression reflects how the drug works. It’s not targeting one condition at a lower dose and another at a higher dose. Many people who take it for depression also find their anxiety improves, and vice versa, because the two conditions frequently overlap and share underlying biology.
Common Side Effects
In clinical trials, the most frequently reported side effects were headache (about 27% of patients, though roughly 24% of people on placebo also reported headaches), nausea (around 11%), stomach pain (about 13%), insomnia (roughly 8%), and fatigue (about 5%). Most of these are mild and tend to ease within the first few weeks as your body adjusts.
Sexual side effects, including reduced desire and difficulty with arousal or orgasm, are a well-known issue with SSRIs as a class. These don’t always appear in early trial data because patients may not report them spontaneously, but they’re common enough that your prescriber should mention them upfront.
Safety Considerations for Younger Patients
All antidepressants, including Lexapro, carry an FDA boxed warning about an increased risk of suicidal thinking and behavior in children, adolescents, and young adults. In pooled analyses across antidepressant trials, the rate of suicidal thoughts or behaviors was about 4% in those taking medication, compared to 2% on placebo. This risk is highest during the first few months of treatment or when doses change.
This warning doesn’t mean the medication is unsafe for young people. It means monitoring matters. Families and caregivers should watch for unusual changes in behavior, increased agitation or irritability, and any new or worsening mood symptoms, especially in the early weeks. These observations should be communicated to the prescriber promptly.
Depression, Anxiety, or Both
In practice, the line between “for anxiety” and “for depression” is blurrier than it looks. Depression and generalized anxiety co-occur more often than not. Studies consistently show that roughly 60% of people with one condition also meet criteria for the other. Because Lexapro treats both through the same serotonin pathway, it’s a practical choice when someone is dealing with overlapping symptoms like persistent low mood, chronic worry, disrupted sleep, and difficulty concentrating.
If you’re wondering whether your prescriber chose Lexapro because of your anxiety, your depression, or both, the answer may simply be that it covers the full picture. The dosing, the timeline, and the expected benefits are essentially the same regardless of which diagnosis prompted the prescription.